$9.70
-0.11-1.12%
가까이에: Sep 22, 5:00 PM EST
$9.58
-0.23-2.34%
프리마켓: 5:13 AM EST
Benzinga
Benzinga
Benzinga
목요일, 9월 24
ADMA Biologics Inc
ADMANASDAQ
ADMA Biologics Earnings & Forecasts
ADMA Biologics (ADMA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ADMA Biologics Guidance
ADMA Biologics (ADMA)는 8월 5, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $530M - $560M 범위로 예상했습니다.
이전 가이던스와 비교하여 ADMA Biologics는 매출 전망치를 이전 범위인 유지됨에서 $530M - $560M로 상향 조정했습니다.
ADMA Biologics은 15과 11월 9, 2022 사이에 8월 5, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.17 | $0.20 | $0.20 | $0.16 |
| Actual | $0.16 | $0.17 | $0.21 | $0.16 |
| Surprise | -5.88% | -15.0% | +7.50% | 0.00% |
| Revenue | ||||
| Estimate | $126.1M | $140.0M | $139.8M | $130.4M |
| Actual | $124.4M | $114.5M | $139.2M | $134.2M |
| Surprise | -1.34% | -18.2% | -0.46% | +2.96% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.20 | $0.24 | $0.17 | $0.20 |
| Revenue | ||||
| Consensus | $138.5M | $157.1M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved